Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: J Behav Med. 2016 Jan 18;39(3):429–440. doi: 10.1007/s10865-016-9716-z

Table 2.

Intercorrelations and descriptive statistics for study variables among men

1 2 3 4 5 6 7 8 9 10
1. Intention to ask doctor for HPV vaccine
 Correlation
p value
2. Perceived severity of genital warts
 Correlation .02
p value .82
3. Perceived risk of genital warts
 Correlation .16 −.06
p value .06 .51
4. Perceived benefits of HPV vaccine against genital warts
 Correlation .13 .08 −.01
p value .12 .36 .87
5. Anticipated regret if unvaccinated and later developed genital warts
 Correlation .22 .29 <.01 .16
p value .01 <.01 .97 .07
6. Perceived severity of HPV-related cancer
 Correlation −.09 .65 −.21 .22 .31
p value .32 <.01 .01 .01 <.01
7. Perceived risk of HPV-related cancer
 Correlation .11 −.06 .74 .07 .10 −.10
p value .21 .51 <.01 .44 .23 .24
8. Perceived benefits of HPV vaccine against HPV-related cancer
 Correlation .20 .02 −.06 .59 .12 .08 .02
p value .02 .80 .50 <.01 .17 .34 .80
9. Anticipated regret if unvaccinated and later developed HPV-related cancer
 Correlation .23 .24 .06 .15 .76 .29 .11 .14
p value .01 <.01 .47 .07 <.01 <.01 .19 .12
10. Have heard of HPV vaccinea
 Correlation −.14 .13 −.15 .05 .00 .23 −.15 .04 .07
p value .11 .12 .09 .53 1.00 .01 .09 .67 .45
Mean 2.15 3.14 2.20 3.04 3.51 3.57 2.10 2.74 3.58 .66
SD .88 .87 .72 .88 .75 .77 .63 .79 .74 .48

N = 137; HPV: human papillomavirus, SD: standard deviation. Statistics significant at p < .05 are denoted in bold

a

Have heard of HPV vaccine was coded as 0 = no and 1 = yes